Development and Management of Registry in Patients With Gynecologic Cancer in Korea
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorAsan Medical Center
About this trial
The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Female patients 18 years or older
Written informed consent (prospective cohort)
Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Disqualifiers
Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer
Trial population
Patients with gynecologic cancer undergoing treatment
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Patient registry
Other interventionClinical data, specific procedures and treatments will follow the Institutional standard operative procedures
Treatment groups
13,500 Participants
are divided into 3 treatment groupsGroup A: Cervical cancer1 intervention
Group B: Endometrial cancer1 intervention
Group C: Ovarian cancer, Fallopian tube cancer, Peritoneal cancer1 intervention
Trial outcomes
Primary outcomes
1
Overall survival
Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to baseline characteristics, surgical methods, and treatment
Time frame
5 yearsSecondary outcomes
1
Progression-free survival
Analyzed for all patients, as time from diagnosis to progression of disease or death as a result of any cause, stratified according to baseline characteristics, surgical methods, and treatment
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov